Board Duties, Conflicts and Approvals in Dutch M&A
Category: InsightsCorporate interest, conflicts of interest and board decision-making in Dutch deals
Directors of a Dutch company play an important role in M&A transactions. Even where shareholders negotiate the economics of the deal, the board must still consider the corporate interest of the company, manage conflicts of interest, supervise information sharing, follow proper decision-making procedures and understand which approvals are required before signing or closing.
In Dutch M&A, this matters because a transaction is not only a shareholder decision. A sale, acquisition, carve-out, investment or management rollover may affect the company, its business, employees, creditors, minority shareholders and future governance. Directors should therefore treat their role as more than a formality.
This article explains the main responsibilities of directors in Dutch M&A transactions and how those responsibilities interact with the SPA, corporate approvals, shareholder information and governance disputes. It forms part of ViottaLaw’s M&A Insights on Dutch deal practice and is closely related to corporate governance, conditions precedent in Dutch M&A deals and signing and closing in Dutch M&A transactions.
Directors must act in the corporate interest
Dutch directors must act in the interest of the company and its business. In an M&A context, that interest is not always identical to the interest of the selling shareholder, the buyer, the investor or the management team.
This becomes relevant when shareholders push for a quick sale, when a buyer wants extensive pre-closing control, when a founder remains involved after closing, or when a transaction creates risks for the company’s employees, creditors, customers or continuity.
The board does not need to second-guess every commercial point negotiated by shareholders. But it should understand the transaction, consider the impact on the company and make sure that the company is not simply treated as an object of the transaction without proper board involvement.
Shareholder approval does not replace board responsibility
Many Dutch M&A transactions require shareholder approval, either under the articles of association, a shareholders’ agreement or the transaction documents. In some cases, approval rights also appear as conditions precedent in the SPA.
However, shareholder approval does not automatically remove the board’s own responsibility. Directors should still consider whether the company can enter into the relevant documents, whether the transaction is in the corporate interest, whether conflicts exist and whether the correct corporate steps are being taken.
This distinction is especially important in Dutch BV structures with investor consent rights, reserved matters or post-closing shareholder arrangements. A shareholders’ agreement may allocate commercial control between shareholders, but the board remains responsible for board-level decision-making. This is also relevant in transactions involving shareholders’ agreements after Dutch acquisitions.
Conflicts of interest must be identified early
Conflicts of interest are common in M&A. A director may also be a selling shareholder. A founder may negotiate a management agreement with the buyer. A management team may receive rollover equity. A shareholder-appointed director may be linked to one side of the transaction. A group director may be involved in both seller and target governance.
These conflicts do not automatically block a transaction, but they should be identified early and handled properly.
The articles of association, board rules and Dutch statutory rules may determine whether a conflicted director can participate in deliberation or decision-making. Even where a director is permitted to be involved, the board should document how the conflict was considered and why the transaction remains supportable from the company’s perspective.
Poor conflict handling can create problems later, especially if minority shareholders, creditors, employees or former shareholders challenge the transaction or its consequences.
Information sharing requires discipline
M&A processes involve sensitive information. Sellers want to inform bidders. Buyers want access to diligence materials. Management may be asked to participate in presentations. Shareholders may request updates. Investors may rely on information rights.
The board should supervise how company information is shared. This includes confidentiality, staged disclosure, competitively sensitive information, employee information, customer contracts, IP, data and commercially sensitive forecasts.
In a competitive sale process, directors should make sure the data room process is structured and that disclosure is consistent with the company’s interests. For more on that process, see ViottaLaw’s articles on legal due diligence in Dutch M&A transactions and management presentations and vendor due diligence in Dutch sale processes.
Decision-making should match the transaction documents
A frequent mistake in Dutch M&A is to agree the commercial deal first and check the corporate decision-making later. That can create timing issues before signing or closing.
Directors should verify early which approvals are required. These may include board approval, shareholder approval, investor consent, approval under the articles, consent under a shareholders’ agreement, works council involvement, regulatory clearance or third-party contractual consent.
The SPA should align with those requirements. If approvals are needed before closing, they may need to be included as conditions precedent. If powers of attorney, notarial deeds or corporate resolutions are required, they should be built into the closing agenda.
For Dutch share deals, this also connects to the notarial mechanics in Dutch share deals and the broader signing-to-closing workstream.
Directors should be careful with pre-closing buyer control
Buyers often want covenants between signing and closing. These may restrict the target from taking certain actions without buyer consent. That can be legitimate, especially where there is a gap between signing and closing.
But directors should be careful that pre-closing covenants do not transfer operational control to the buyer too early. Until closing, the seller still owns the shares and the target board remains responsible for the company.
This is particularly relevant where regulatory clearance is required, where the buyer is a competitor, or where sensitive information is shared before closing. Interim covenants should preserve deal value without undermining board autonomy or creating inappropriate control before completion.
Governance disputes can affect deal certainty
Director responsibilities become especially sensitive when shareholders disagree. A minority shareholder may object to a sale. A founder may disagree with an investor-appointed director. Management may support a transaction that some shareholders oppose. A deadlock may prevent required approvals.
In those situations, the M&A process becomes a governance issue. The board should carefully document its decision-making, the information considered, the conflicts identified and the reasons for its position.
Governance disputes can affect timing, conditions precedent, disclosure, warranties and even the buyer’s willingness to proceed. Where the relationship between shareholders is already strained, the transaction documents should take approval risk and dispute risk seriously. ViottaLaw’s articles on deadlock in a Dutch BV and shareholder disputes in the Netherlands discuss these issues in more detail.
Practical points for boards in Dutch M&A
Directors should address governance early in the transaction process. Before signing, the board should understand the transaction structure, conflicts of interest, required approvals, information-sharing process, authority to sign, closing deliverables and any post-closing role for management.
The board should also ensure that minutes and resolutions are clear enough to show that the relevant issues were considered. That does not mean creating excessive paperwork. It means making sure the corporate record supports the transaction.
In cross-border deals, this is particularly important because international transaction documents may assume a decision-making process that does not fully match Dutch BV governance.
Conclusion
Directors’ responsibilities in Dutch M&A transactions are not merely procedural. The board must consider the corporate interest, handle conflicts, supervise information sharing, follow proper decision-making and ensure that shareholder approvals and transaction documents align with Dutch corporate requirements.
For buyers, sellers and investors, good board process improves deal certainty. For directors, it reduces the risk that the transaction later becomes a governance dispute.
The practical lesson is simple: board authority, conflicts, approvals and information-sharing rules should be checked before the SPA is finalized, not in the final days before closing.
FAQ
Do directors decide whether a Dutch company can be sold?
That depends on the structure and the company’s articles and shareholder arrangements. Shareholders may approve or decide on a sale of shares, but the board may still have responsibilities where the company itself enters into documents, provides information, supports the process or is affected by the transaction.
Can a director who is also a selling shareholder participate in board decisions?
Possibly, but conflicts of interest must be assessed carefully. The articles, board rules and Dutch law may affect whether the director can participate in deliberation or decision-making.
Is shareholder approval enough in a Dutch M&A transaction?
Not always. Shareholder approval may be required, but the board must still consider its own responsibilities, signing authority, corporate interest, conflicts and implementation steps.
Why does information sharing matter for directors?
Because M&A due diligence often involves confidential, commercially sensitive or personal information. The board should ensure that information is shared in a controlled way and in the company’s interest.
When should director approvals be checked?
Early in the process, preferably before the SPA or investment agreement is finalized. Required approvals may affect conditions precedent, closing deliverables and timing.
About Dirk de Waard
Dirk de Waard is a Dutch corporate and M&A lawyer and partner at Venture Lawyers in Amsterdam. He writes on ViottaLaw about Dutch M&A, private equity, venture capital and governance, and advises founders, investors, management teams, buyers and sellers on Dutch transaction implementation through Venture Lawyers.
Dealing with board responsibilities in a Dutch M&A transaction?
Board authority, conflicts of interest, shareholder approvals and information-sharing rules can affect signing, closing and post-closing governance.
Dirk de Waard advises buyers, sellers, investors and management teams on Dutch M&A transactions and governance issues. Contact Dirk at dirk.dewaard@viottalaw.com to discuss director responsibilities, corporate approvals or governance issues in a Dutch transaction.
